SK282649B6 - Protilátka proti CD44v6, hybridómová bunková línia, molekula protilátky a jej použitie - Google Patents
Protilátka proti CD44v6, hybridómová bunková línia, molekula protilátky a jej použitie Download PDFInfo
- Publication number
- SK282649B6 SK282649B6 SK1548-96A SK154896A SK282649B6 SK 282649 B6 SK282649 B6 SK 282649B6 SK 154896 A SK154896 A SK 154896A SK 282649 B6 SK282649 B6 SK 282649B6
- Authority
- SK
- Slovakia
- Prior art keywords
- antibody
- vff
- antibodies
- binding
- cell line
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4419913 | 1994-06-08 | ||
DE19944431297 DE4431297A1 (de) | 1994-09-02 | 1994-09-02 | Monoklonaler Antikörper gegen CD44v6 |
PCT/EP1995/002126 WO1995033771A1 (de) | 1994-06-08 | 1995-06-02 | MONOKLONALER ANTIKÖRPER GEGEN CD44v6 |
Publications (2)
Publication Number | Publication Date |
---|---|
SK154896A3 SK154896A3 (en) | 1997-08-06 |
SK282649B6 true SK282649B6 (sk) | 2002-10-08 |
Family
ID=25937246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1548-96A SK282649B6 (sk) | 1994-06-08 | 1995-06-02 | Protilátka proti CD44v6, hybridómová bunková línia, molekula protilátky a jej použitie |
Country Status (28)
Country | Link |
---|---|
US (1) | US5916561A (ru) |
EP (1) | EP0765343B1 (ru) |
JP (2) | JP3387929B2 (ru) |
KR (2) | KR100379217B1 (ru) |
CN (1) | CN1125083C (ru) |
AT (1) | ATE197592T1 (ru) |
BG (1) | BG64181B1 (ru) |
BR (1) | BR9507964A (ru) |
CA (1) | CA2192370A1 (ru) |
CO (1) | CO4410258A1 (ru) |
CZ (1) | CZ291274B6 (ru) |
DE (1) | DE59508864D1 (ru) |
DK (1) | DK0765343T3 (ru) |
ES (1) | ES2151603T3 (ru) |
FI (1) | FI964845A0 (ru) |
GR (1) | GR3035388T3 (ru) |
HK (1) | HK1011697A1 (ru) |
HU (1) | HU220168B (ru) |
NO (1) | NO317948B1 (ru) |
NZ (1) | NZ288224A (ru) |
PL (1) | PL190897B1 (ru) |
PT (1) | PT765343E (ru) |
RO (1) | RO118753B1 (ru) |
RU (1) | RU2204606C2 (ru) |
SI (1) | SI0765343T1 (ru) |
SK (1) | SK282649B6 (ru) |
UA (1) | UA58482C2 (ru) |
WO (1) | WO1995033771A1 (ru) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY24389A1 (es) * | 1995-12-06 | 2001-10-25 | Karlsruhe Forschzent | Composición farmacéutica para el tratamiento de carcinoma de epitelio plano |
US6440733B1 (en) * | 1996-02-15 | 2002-08-27 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibodies recognizing antigens on the surface of endothelial cells of tumor vessel |
DE19648209A1 (de) * | 1996-11-21 | 1998-05-28 | Boehringer Ingelheim Int | Verfahren zur Tumorzelldepletion CD34-positiver Zellen |
DE19708713C2 (de) * | 1997-03-04 | 2002-11-28 | Boehringer Ingelheim Int | Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen |
ATE369425T1 (de) | 1998-06-08 | 2007-08-15 | Fuso Pharmaceutical Ind | Antikörper gegen eine lar-phosphatase untereinheit |
ATE411386T1 (de) * | 1998-07-10 | 2008-10-15 | Fuso Pharmaceutical Ind | Antikörper gegen intrazelluläre domänen der protein tyrosin phosphatase |
US7947496B2 (en) * | 1999-10-08 | 2011-05-24 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US7189397B2 (en) * | 1999-10-08 | 2007-03-13 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US8071072B2 (en) * | 1999-10-08 | 2011-12-06 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US20050100542A1 (en) * | 1999-10-08 | 2005-05-12 | Young David S. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US8048416B2 (en) * | 1999-10-08 | 2011-11-01 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US20090004103A1 (en) * | 1999-10-08 | 2009-01-01 | Young David S F | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US20080124327A1 (en) * | 1999-10-08 | 2008-05-29 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
BR0210905A (pt) * | 2001-05-18 | 2004-06-08 | Boehringer Ingelheim Int | Anticorpos especìficos para cd44v6 |
US20030103985A1 (en) * | 2001-05-18 | 2003-06-05 | Boehringer Ingelheim International Gmbh | Cytotoxic CD44 antibody immunoconjugates |
US6972324B2 (en) | 2001-05-18 | 2005-12-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Antibodies specific for CD44v6 |
WO2003018044A1 (en) * | 2001-08-24 | 2003-03-06 | Stroemblad Staffan | New drug |
US20040126379A1 (en) * | 2002-08-21 | 2004-07-01 | Boehringer Ingelheim International Gmbh | Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents |
US20040110933A1 (en) * | 2002-09-13 | 2004-06-10 | Dyax Corporation | CD44-binding ligands |
US20040120949A1 (en) * | 2002-11-08 | 2004-06-24 | Boehringer Ingelheim International Gmbh | Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy |
US20060140963A1 (en) * | 2003-04-14 | 2006-06-29 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD59 |
EP1806365A1 (en) | 2006-01-05 | 2007-07-11 | Boehringer Ingelheim International GmbH | Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
EP2266593A1 (en) | 2009-06-24 | 2010-12-29 | Karlsruher Institut für Technologie | Use of CD44v6 in the treatment of ophthalmic diseases |
CA2771441C (en) * | 2009-08-19 | 2016-10-11 | Merck Patent Gmbh | Antibodies for the detection of integrin complexes in ffpe material |
CN102337298B (zh) * | 2011-08-19 | 2013-11-06 | 黄开红 | 一种输送siRNA的免疫纳米载体及其制备方法和应用 |
EP2886126B1 (en) | 2013-12-23 | 2017-06-07 | Exchange Imaging Technologies GmbH | Nanoparticle conjugated to CD44 binding peptides |
AU2018409898A1 (en) * | 2018-02-22 | 2020-09-24 | Multitude Inc. | Therapeutic antibody and uses thereof |
CN109593125A (zh) * | 2018-12-12 | 2019-04-09 | 深圳市龙华区人民医院 | 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p1及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08506801A (ja) * | 1992-11-20 | 1996-07-23 | アイシス・イノベーション・リミテッド | Cd44エキソン6に対応するペプチド、そのペプチドに特異的な抗体、および、腫瘍診断にそれらの抗体を使用する方法 |
DK0703989T3 (da) * | 1993-06-18 | 1998-02-09 | Biotie Therapies Oy | Præparater og diagnostiske fremgangsmåder under anvendelse af monoklonale antistoffer mod CD44v6 |
WO1995000851A1 (de) * | 1993-06-22 | 1995-01-05 | Boehringer Ingelheim International Gmbh | Verfahren zur diagnose und analyse von tumoren |
-
1995
- 1995-02-06 UA UA97010045A patent/UA58482C2/ru unknown
- 1995-06-02 SI SI9530457T patent/SI0765343T1/xx unknown
- 1995-06-02 RU RU97100179/13A patent/RU2204606C2/ru not_active IP Right Cessation
- 1995-06-02 EP EP95922496A patent/EP0765343B1/de not_active Expired - Lifetime
- 1995-06-02 ES ES95922496T patent/ES2151603T3/es not_active Expired - Lifetime
- 1995-06-02 SK SK1548-96A patent/SK282649B6/sk unknown
- 1995-06-02 NZ NZ288224A patent/NZ288224A/en unknown
- 1995-06-02 BR BR9507964A patent/BR9507964A/pt not_active IP Right Cessation
- 1995-06-02 PL PL317536A patent/PL190897B1/pl not_active IP Right Cessation
- 1995-06-02 HU HU9603387A patent/HU220168B/hu not_active IP Right Cessation
- 1995-06-02 CZ CZ19963591A patent/CZ291274B6/cs not_active IP Right Cessation
- 1995-06-02 KR KR1019960706939A patent/KR100379217B1/ko not_active IP Right Cessation
- 1995-06-02 PT PT95922496T patent/PT765343E/pt unknown
- 1995-06-02 DK DK95922496T patent/DK0765343T3/da active
- 1995-06-02 AT AT95922496T patent/ATE197592T1/de active
- 1995-06-02 DE DE59508864T patent/DE59508864D1/de not_active Expired - Lifetime
- 1995-06-02 JP JP50035496A patent/JP3387929B2/ja not_active Expired - Fee Related
- 1995-06-02 CN CN95194169A patent/CN1125083C/zh not_active Expired - Fee Related
- 1995-06-02 CA CA002192370A patent/CA2192370A1/en not_active Abandoned
- 1995-06-02 RO RO96-02287A patent/RO118753B1/ro unknown
- 1995-06-02 US US08/750,359 patent/US5916561A/en not_active Expired - Lifetime
- 1995-06-02 WO PCT/EP1995/002126 patent/WO1995033771A1/de active IP Right Grant
- 1995-06-07 CO CO95024702A patent/CO4410258A1/es unknown
-
1996
- 1996-12-03 BG BG101024A patent/BG64181B1/bg unknown
- 1996-12-04 FI FI964845A patent/FI964845A0/fi not_active IP Right Cessation
- 1996-12-05 KR KR1019967006939A patent/KR970703368A/ko unknown
- 1996-12-06 NO NO19965239A patent/NO317948B1/no not_active IP Right Cessation
-
1998
- 1998-12-07 HK HK98112912A patent/HK1011697A1/xx not_active IP Right Cessation
-
2001
- 2001-02-07 GR GR20010400215T patent/GR3035388T3/el not_active IP Right Cessation
-
2002
- 2002-06-19 JP JP2002178280A patent/JP2003034700A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK282649B6 (sk) | Protilátka proti CD44v6, hybridómová bunková línia, molekula protilátky a jej použitie | |
DK172440B1 (da) | Monoklonale antistoffer og derivater deraf, fremgangsmåde til deres fremstilling, hybridomacellelinie og fremgangsmåde til | |
US7183384B2 (en) | Monoclonal antibody 7H11 reactive with human cancer | |
EP3029069B1 (en) | Anti-human cd26 monoclonal antibody or antigen-binding fragment thereof | |
KR101682257B1 (ko) | 인간 cxcl1 단백질의 면역학적 측정 방법 | |
CN113321731A (zh) | 结合人程序性死亡配体1(pd-l1)的抗体 | |
EP3653644A1 (en) | Monoclonal antibodies to growth and differentiation factor 15 (gdf-15), and uses thereof for treating cancer cachexia and cancer | |
US20220119546A1 (en) | Plectin-1 binding antibodies and uses thereof | |
KR20080106157A (ko) | Fas 결합 항체 | |
EP1001020A1 (en) | Antihuman pre-b cell receptor antibodies | |
KR100473824B1 (ko) | 상피종의진단및치료방법 | |
US7560095B2 (en) | Cancer specific monoclonal antibodies | |
KR20120118412A (ko) | 인간 간-카르복실에스터라제 1을 특이적으로 인식하는 단일클론 항체, 상기 항체를 생산하는 하이브리도마 세포주 및 이의 용도 | |
JPWO2006085441A1 (ja) | Adamts13活性検定用抗体及び活性検定方法 | |
CA2607930A1 (en) | Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof | |
CA1334176C (en) | Monoclonal antibody recognizing gamma atrial natriuretic polypeptide | |
JP2955082B2 (ja) | ヒトカルシトニンのn末端部分を特異的に認識するモノクローナル抗体 | |
CN113597432A (zh) | 抗EpCAM抗体及其应用 | |
JP2792651B2 (ja) | ヒト膵臓癌に対するモノクローナル抗体 | |
KR100493932B1 (ko) | 레지스틴에 대한 단클론 항체, 이의 제조 방법, 및 용도 | |
JP4037933B2 (ja) | 抗ヒトカルシトニンモノクローナル抗体 | |
JP2925479B2 (ja) | 肺小細胞癌検出薬及びその使用 | |
US9163080B2 (en) | Anti-single-chain type IV collagen polypeptide antibody, pharmaceutical drug, diagnostic, preventive, or therapeutic drug for tumour containing the antibody | |
JPH04183397A (ja) | ヒト72kDaゼラチナーゼに対するモノクローナル抗体およびその利用 | |
CN111138541B (zh) | 一种肿瘤干细胞检测试剂盒 |